New Survey Shows Product Liability Litigation May Jeopardize 
Treatment Outcomes for People with Severe Mental Illnesses

ROCKVILLE, Md., June 13 /PRNewswire/ -- Survey results released today 
shed light on a new barrier to treatment affecting people with severe 
mental illness. The findings show fears raised by product liability 
litigation involving antipsychotic drugs may be putting patients with 
schizophrenia and bipolar disorder at risk for relapse. These fears 
add to the already heavy burden that patients face as they work to 
manage symptoms, stay on their medication and work with their 
treatment providers to improve their mental and physical health.

http://www.therapeuticsdaily.com/news/article.cfm?contentvalue=1388675&contenttype=sentryarticle&channelID=30


"People Who experience mood swings, fear, voices and visions"